Observational studyCritical care (London, England)2025
Subphenotypes of mechanically ventilated acute respiratory distress syndrome patients based on multi-dimensional pathophysiological parameters.
Observational study in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond One-Size-Fits-All: Precision Mechanical Ventilation in ARDS.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute respiratory distress syndrome (ARDS) is a life-threatening condition with significant heterogeneity in pathophysiology. The integration of pulmonary edema indices, respiratory mechanics, and gas exchange parameters to define subphenotypes in mechanically ventilated patients with ARDS has not yet been investigated.
methodsWe conducted a post hoc analysis of a prospective observational study with a derivation cohort (n = 111). We applied K-means clustering to identify distinct subphenotypes based on key physiological parameters: pulmonary edema indices, respiratory mechanics, and gas exchange variables. The primary outcome was 28-day mortality. Between-group differences in 28-day mortality were analyzed using the chi-square test. Survival analysis was performed with Kaplan-Meier curves (compared by log-rank test) and multivariable Cox regression to adjust for covariates. Furthermore, we compared the differential responses to prone positioning ventilation among the identified subphenotypes to evaluate its potential interaction effect on mortality. An independent validation cohort (n = 55) was used to confirm the subphenotype classifications and their relationships with clinical outcomes.
resultsUnsupervised clustering revealed two distinct subphenotypes. Subphenotype 2, characterized by elevated pulmonary vascular permeability index (PVPI) and ventilation ratio (VR), demonstrated significantly higher 28-day mortality compared to Subphenotype 1 (50.0% vs. 28.2%, p = 0.021). This survival disadvantage was confirmed by Kaplan-Meier analysis (log-rank p = 0.016) and a multivariable Cox regression model (adjusted hazard ratio [HR] 2.263, 95% confidence interval [CI] 1.206-4.245; p = 0.011). Furthermore, a statistically significant interaction was observed between subphenotypes and response to prone positioning for 28-day mortality (p-for-interaction = 0.015). Crucially, the prognostic distinction between subphenotypes and their differential treatment response were consistently replicated in an independent validation cohort.
conclusionsUsing unsupervised machine learning, this study identified two distinct ARDS subphenotypes characterized by divergent profiles in pulmonary edema, respiratory mechanics, and gas exchange. These subphenotypes were associated with significantly different clinical outcomes and exhibited a differential response to prone positioning therapy. Future research should prioritize the execution of large-scale, multicenter, randomized controlled trials to validate these findings and advance the clinical implementation of precision medicine in the management of ARDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.